Last update: Dec. 26, 2020
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
Although in some published series no breastfeeding problems have been found (Jewell 2019), after a surgery for augmentation mammoplasty there is a higher risk for lactation failure (Marcacine 2018) with a lower incidence of exclusive breastfeeding (Cheng 2018, Schiff 2014, Andrade 2010, Zuckerman 2010) and an increased need of effective support among women who are carriers of breast implants (Roberts 2015).
Involved factors are many:
1- Lost of sensibility and erection capacity of the nipple and disruption of the neuro-endocrine reflex due to section of lateral and medial branches of the 4th-intercostal nerve or neural endings of the areola-nipple complex, depending on type of surgery, may decrease the milk production.
2- Pain of the breast due to pressure from the implant or contraction of the capsule.
3- Possibly, higher incidence of mammary hypoplasia among women with breast implants.
There is a higher risk of breastfeeding problems with retro-glandular implants than with retro-muscular implants (Bompy 2019, Marcacine 2018).
Rare complications are: galactorrhea that is usually treatable and transient, galactocele, prosthesis rotation, seroma and excessive inflammation in the post-natal period (Zolotykh 2019, Basile 2015, Irkoren 2013, Meggiorini 2013, Yang 2012, Ayestaray 2012, Tung 2011, Chun 2009).
The majority of breast implants contain silicone, which is a polymer made out of silicon-oxygen-methyl combination with a high molecular weight, which makes it practically impossible both to pass into milk in significant quantity and subsequent intestinal absorption by the infant. Those circumstances make silicone implants safe for lactation even if broken or manufacturing fault (Poly Implant Prothèse, PIP). After extensive analysis of such silicone prosthesis, lack of health risk was demonstrated (SCENIHR 2013).
Silicon levels in blood and milk of women with implants (55 ng / ml) are similar to those of women without implants (51 ng / ml), 13 times lower than that found in cow's milk (709 ng / ml) and 80 times lower than in commercial infant formulas (4403 ng / ml).
Injections with Polyacrylamide hydrogel that are used for augmentation of the breast volume have been discouraged in many countries, because they are too often related to complications while breastfeeding or not (Bourke 2018, Wang 2012, Kang 2011, Cheng 2011).
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana from Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM